SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Elixir network is a new primitive, purpose-built to power the next generation of institutional liquidity. Elixir powers deUSD – a fully collateralized, yield-bearing synthetic dollar.   Elixir is the most widely adopted network by RWAs: exclusively bringing funds from BlackRock, Hamilton Lane, and others to DeFi for the first time through deUSD. The Elixir network is secured by 30,000+ global validators.

Elixir

Elixir is seeing significant momentum and high social media visibility as traders characterize it as a holiday weekend runner. While many community members celebrate the rapid price appreciation, others are raising concerns regarding the depegging of associated stablecoin assets.

Bonfida is known as the top infrastructure developer on Solana. This accolade has been earned from their contributions to the ecosystem by providing services and products that allow for the wider ecosystem to flourish.  Their contributions to the ecosystem include creating a new Serum Core engine, the Asset Agnostic Orderbook (AOB), simplifying the way users transact on Solana, and the first perpetual swap on Solana, Audaces, to name a few. As a result of these, their developers are highly respected within the Solana ecosystem.

Bonfida

Bonfida is seeing a surge in community engagement and trading volume as investors draw comparisons to recent parabolic rallies in the Solana ecosystem. The discussion is heavily centered on technical chart patterns and speculation regarding a potential breakout, with many market participants actively debating whether to accumulate for long-term growth or trade the momentum.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA crypto token continues to face intense scrutiny and skepticism from the community, with many investors labeling it a pump-and-dump scheme associated with the Trump family. Discussion is heavily focused on the coin's dramatic value collapse, ongoing controversy surrounding its project utility, and community members expressing strong resentment over financial losses.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is currently trending as community members rally around its focus on cannabis culture and its potential for real-world integration in the industry, despite ongoing debate regarding its long-term value and price volatility. Supporters are actively engaging with marketing efforts and building long-term conviction, while skeptics continue to voice concerns about the lack of fundamental utility.

Gitlawb is a decentralized code collaboration platform designed for AI agents and human developers. It provides a Git-compatible hosting layer where repositories are stored across IPFS, Filecoin, and Arweave, and peer connectivity is handled through libp2p rather than a central server.  Identity on Gitlawb is based on decentralized identifiers (DIDs) using Ed25519 keys. Access control and delegation between users and agents are expressed as UCAN (User Controlled Authorization Networks) capabilities, allowing scoped, revocable permissions to be granted without a central authority. Each identity carries an on-chain trust score derived from verified contributions.  The protocol is accessed through three main surfaces: a Rust node (gitlawb-node) that serves repositories over HTTP and libp2p, a command-line client (gl) that handles identity, repositories, issues, bounties, and UCAN delegation, and a git remote helper (git-remote-gitlawb) that allows standard Git clients to push and pull using gitlawb:// URLs.  Additional products in the ecosystem include MiroClaw, an on-chain prediction market; Gitlawb Spawn, an AI agent orchestration tool; OpenClaude, an open-source agent harness aligned with Playground and Spawn; and a developer playground for testing agent interactions against the protocol.

Gitlawb

Gitlawb is trending as investors rally behind its vision of a decentralized, AI-native infrastructure for autonomous agents, bolstered by anticipation of strategic partnerships and token buyback programs. Community sentiment remains highly optimistic, with many focusing on the project's long-term utility and its potential to disrupt traditional centralized code repositories.

Plume is the first RWAfi L1 network focused on crypto natives. We build infrastructure to make it easy to connect the real world and the crypto markets. We go against the traditional view of RWAs by changing its definition – it’s not just TradFi onchain but instead building net new crypto-first RWA use cases to the market including things like RWA derivatives/speculation, borrow/lend, yield farming, and more.  We are a permissionless EVM chain and ecosystem that is redefining and driving the RWA market forward. We do this through novel technologies that vertically integrate all the elements of RWAs into a single stack and ecosystem. Our tokenization engine, an EVM chain, compliance &amp; regulatory tooling, RWA data normalization, etc are all first class objects so that they work seamlessly together to make it easy to bring anything in the real world (assets, data, etc.) onchain.

Plume Network

Plume Network is trending as investors focus on its specialized RWA (Real-World Asset) infrastructure and recent institutional-grade integrations with firms like Apollo and Centrifuge. The community is actively discussing its potential for long-term growth, comparing its trajectory to other established RWA projects while closely watching for broader exchange listings and mainnet developments.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is gaining significant momentum as the community highlights high conviction and ongoing token supply locks as key indicators of long-term strength. Investors are actively discussing the project's brand development and upcoming anniversary, fueling a sentiment that the ecosystem is positioned for a breakout.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as investors highlight its massive user growth and the recent reduction in token inflation alongside its integration with AI-powered infrastructure. The community is actively discussing the protocol's role in the 'agentic economy' and cross-chain functionality, driving sentiment around its potential as a core utility asset.

dogwifhat (WIF) is a Solana-based memecoin featuring a Shiba Inu dog wearing a pink knitted hat that has become a central figure in the 2024-2026 market. Originally launched anonymously in late 2023, the project operates on a decentralized, community-driven model with no formal venture capital backing or complex tokenomics. It represents a cultural phenomenon on the Solana blockchain that celebrates whimsy and simplicity over technical complexity, focusing on its identity as a playful mascot for the digital finance era. The project’s main value proposition is its "Pure Meme Identity," as it maintains a strict focus on its meme origins without forced utility or a pivot toward DeFi and gaming.  The project embodies the community-driven nature of the Solana ecosystem, prioritizing "vibes" and meme-sharing as its primary growth drivers. It follows a "hat stays on" philosophy, maintaining a singular focus on its core meme rather than building a complex ecosystem. While the project does not have a formal governance structure or DAO, decisions are largely driven by social consensus among the community and key influencers. Notable community initiatives include the "Sphere Wif Hat" campaign, which raised nearly $700,000 in USDC in March 2024 to put the mascot on the Las Vegas Sphere. However, after a year of negotiations and delays, organizers officially abandoned the advertisement on March 31, 2025, and initiated a full refund process for donors.  The initial team behind dogwifhat remains anonymous, which is a standard practice within the memecoin sector. The coin's narrative is heavily influenced by prominent crypto personalities, most notably Ansem, who was a key figure in the project's early viral growth and subsequent marketing initiatives. Regarding integrations, WIF has deep liquidity across major Solana decentralized exchanges like Jupiter and Raydium, is available on the Unichain network via official contract bridging, and is listed on major centralized exchanges including Binance, Coinbase, Kraken, and Bybit.  WIF is a purely speculative asset whose value is primarily driven by community sentiment and meme culture rather than traditional utility. It was launched without a presale or significant venture capital allocation, meaning the token's supply is fully circulating. The project has achieved a "blue chip" status in the memecoin space, often serving as a beta-play for the broader health of the Solana ecosystem. No native decentralized applications or trading bots have been officially launched by the core team, as the project maintains its focus on its identity as "literally a dog wif a hat".

dogwifhat

Dogwifhat (WIF) is facing significant community frustration as the token struggles with persistent sideways price action, leading to heated debates between traders holding for a potential recovery and those labeling the asset a failed investment. While some users are actively discussing long-term price predictions and hoping for an altcoin season to ignite momentum, others remain critical of the coin's lack of utility and its recent tendency to lag behind broader market movements.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is currently a top focus for biotech investors due to the ongoing speculation regarding a significant acquisition, with institutional analysts actively upgrading price targets based on the high strategic value of its multi-selective RAS(ON) inhibitor pipeline. The market is closely watching for potential deal news while balancing the company's valuation against its potential to transform oncology standards of care for RAS-mutant cancers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Intellia's Pipeline Push Drive Long-Term Growth Amid Rivalry?

NTLA advances late-stage studies for nex-z and starts FDA filing for lonvo-z, positioning its pipeline for potential long-term growth.

NTLA Q1 Earnings Beat Estimates, Revenues Miss Mark, Pipeline in Focus

Intellia cuts its Q1 loss, advances late-stage gene-editing programs and plans a 2027 launch for lonvo-z after strong phase III HAE data.

Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Misses Revenue Estimates

Intellia Therapeutics (NTLA) delivered earnings and revenue surprises of +11.60% and -3.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates

Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -50.00% and +0.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Intellia Therapeutics (NTLA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Beats Revenue Estimates

Arcutis Biotherapeutics (ARQT) delivered earnings and revenue surprises of -438.92% and +6.30%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Key PointsArk Invest added to existing positions in Shopify, Intellia Therapeutics, and GeneDX on Tuesday...

NTLA Q2 EPS Increased by Brookline Capital Markets

Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) - Stock analysts at Brookline Capital Markets upped their Q2 2026 EPS estimates for Intellia Therapeutics in a report released on Wednesday, April 29th. Brookline Capital Markets analyst L. Cann now anticipates that the company will earn ($0.75...

Cathie Wood buys $14.1 million of megacap tech stock

Cathie Wood, chief of Ark Investment Management, often trades during earnings season.This time, the timing worked. She picked up shares of a megacap tech company just before results, and the stock...

Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Down - What's Next?

Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Down - What's Next...

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.81	--	--	N/A
Q1 '26	-$0.91	-$0.81	11.06%	BEAT
Q4 '25	-$0.94	-$0.83	11.81%	BEAT
Q3 '25	-$1.01	-$0.92	8.50%	BEAT
Q2 '25	-$1.02	-$0.98	3.70%	BEAT

NTLA
Intellia Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest NTLA News

NTLAIntellia Therapeutics Inc